Imugene Small Caps Presentation, page-2

supercendol: I do like your introduction a lot, as English is the third foreign language I learned in school and I also still worry about making a lot of mistakes.
But, to me at least, you have done a fantastic report which made for some very, very interesting reading. Many THANKS indeed !

That Leslie came across as being an 'honest and most credible source of information' does not surprise me in the least - I was fortunate enough to meet her in person sometime last year on one of her business trips to Asia. And I got the same 'vibes' about her for certain!

What I found to be highlights in your summary are - especially - the following points:

a) Share Price/Market Cap: "Axel said we're still undervalued even at $ 100 MC."
This fully CONFIRMS my view !

b) IP: "Imugene puts IP on every single thing they have."
This is so very SMART and constantly adds VALUE to Imugene - JIMHO, of course.

c) Potential Deal & Phase 3 Trial: "She said she's not even worried about Ph3 as they will probably get a deal before then."
This is fully in line with my thinking. In fact I do hope that a deal will not come 'too early' when Imugene is still at too low a share-price level !! Time will tell on that as usual.

In closing: Once again many THANKS for your SUPER effort, "supercendol".

All the best to all IMU holders and buyers.

wasa